OPK OPKO Health, Inc.
Healthcare$1.29+1.57%ClosedMarket Cap: $974.1M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
0.80
P/S
1.65
EV/EBITDA
-9.01
DCF Value
$0.09
FCF Yield
-18.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
22.7%
Operating Margin
-34.9%
Net Margin
-36.6%
ROE
-16.8%
ROA
-11.5%
ROIC
-10.9%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $124.2M | 21.6% | $-51.0M | $-54.8M | $— | — |
| Q4 null | $148.4M | 30.3% | $-38.3M | $-31.3M | $— | — |
| FY null | $606.9M | 21.1% | $-219.0M | $-225.7M | $— | — |
| Q3 null | $151.7M | 20.0% | $-53.5M | $21.6M | $— | — |
| Q2 null | $156.8M | 19.1% | $-60.0M | $-148.4M | $— | — |
| Q1 null | $150.0M | 15.2% | $-67.2M | $-67.6M | $— | — |
| Q4 null | $183.6M | 46.1% | $-33.1M | $14.0M | $— | — |
| FY null | $713.1M | 43.6% | $-152.1M | $-53.2M | $— | — |
| Q3 null | $173.6M | 23.1% | $14.2M | $24.9M | $— | — |
| Q2 null | $182.2M | 28.4% | $-61.7M | $-10.3M | $— | — |
| Q1 null | $173.7M | 24.2% | $-71.5M | $-81.8M | $— | — |
| Q4 2023 | $181.9M | 24.6% | $-69.0M | $-66.5M | $-0.09 | — |